Found 17 matching trials
Single Doses of ZP4207 Adm. sc to Hypoglycemic TD1 pt. to Describe the PK and PD of ZP4207 as Comp. to Marketed Glucagon
PHASE2The trial is a single-centre, randomized, double-blind, parallel trial in G...
Location
Profil Institut für Stoffwechselforschung GmbH
ZP4207(Dasiglucagon) Administered to T1D Patients to Assess the PK and PD Compared to Marketed Glucagon
PHASE2The trial is a single-centre, randomised, sequential, cross-over trial asse...
Location
Profil Institut für Stoffwechselforschung GmbH
A Trial to Compare the Efficacy and Safety of 2 Different Batches of Subcutaneous Dasiglucagon in Patients With T1DM
PHASE3A randomized, double-blind, crossover trial to compare the efficacy and saf...
Location
LMC Diabetes & Manna Research
A Two-Period Open-label Trial Evaluating Efficacy and Safety of Dasiglucagon in Children With Congenital Hyperinsulinism
PHASE3The objective of the trial is to evaluate the efficacy and safety of dasigl...
Location
Children's Hospital of Colorado
Treatment of Post-bariatric Hypoglycaemia
PHASE2This is an investigator-initiated, proof-of-concept, randomised, double-bli...
Location
Center for Clinical Metabolic Research, Herlev-Gentofte Hospital
Dasiglucagon in the Treatment of Postprandial Hypoglycaemia After Roux-en-Y Gastric Bypass
PHASE2The aim of this study is investigating the effect of a novel glucagon analo...
Location
Center for Clinical Metabolic Research, Herlev-Gentofte Hospital
Multiple Ascending Doses of ZP4207 Administered to HV to Evaluate the Safety, Tolerability, PKs and PDs of ZP4207
PHASE1The trial is a single-centre, randomized, double-blind, phase 1b trial of m...
A Trial to Evaluate the Immunogenicity of Dasiglucagon and GlucaGen in Patients With Type 1 Diabetes Mellitus
PHASE3The trial's objective is to evaluate the immunogenicity of repeated single ...
Single Ascending Doses of ZP4207 Administered in HV and in T1D to Evaluate Safety, Tolerability PKs and PDs of ZP4207 Compared to a Comparator
PHASE1The trial is a randomized, double-blind First in Human trial to evaluate th...
A Trial to Confirm the Efficacy and Safety of Dasiglucagon in the Treatment of Hypoglycemia in Type 1 Diabetes Subjects
PHASE3The objective of the trial is to demonstrate superiority of dasiglucagon co...